Palatin Technologies (OTCMKTS:PTNT) Stock Passes Above 200 Day Moving Average – Should You Sell?

Palatin Technologies, Inc. (OTCMKTS:PTNT)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $9.99 and traded as high as $26.97. Palatin Technologies shares last traded at $26.44, with a volume of 206 shares.

Palatin Technologies Price Performance

The stock has a market cap of $25.73 million, a P/E ratio of -17.06 and a beta of 0.75. The company has a fifty day moving average of $17.47 and a 200 day moving average of $9.99.

Palatin Technologies Company Profile

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy.